Clinical study regarding angioplasty and intraarterial-tPA for intravenous-tPA resistant patients with hyperacute ischemic stroke

Clinical study regarding angioplasty and intraarterial-tPA for intravenous-tPA resistant patients with hyperacute ischemic stroke - Transluminal angioplasty and IA-tPA for IV-tPA resistant patient

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002809

Enrollment

Registered

2009-11-28

Start date

2009-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperacute cerebral major vessel occlusion

Interventions

intraarterial tPA administration and percutaneous transluminal angioplasty

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patient received intravenous tPA within 3 hours after onset, and resistant to this treatment both neurologically and angiographically

Exclusion criteria

Exclusion criteria: When intravascular treatment is judged as difficult

Design outcomes

Primary

Measure	Time frame
ADL (modified Rankin scale) at 90 days after the treatment	—

Countries

Japan

Contacts

Public ContactShinichi Yoshimura

Graduate School of Medicine, Gifu University Department of Neurosurgery

s-yoshi@gifu-u.ac.jp+81-58-230-6271

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026